Skip to content

A One Health Study of Monkeypox Human Infection

A One Health Study of Monkeypox Human Infection, Animal Reservoir, Disease Ecology and Diagnostic Tools

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05058898
Acronym
AFRIPOX
Enrollment
280
Registered
2021-09-28
Start date
2021-09-09
Completion date
2023-12-31
Last updated
2023-12-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Monkeypox Virus Infection

Keywords

epidemiology, outbreak investigation, anthropology,, animal reservoir, zoonotic disease, field diagnosis

Brief summary

This multidisciplinary project aim to understand the epidemiology of the monkeypox in Central African Republic through the identification of the animal reservoir, the clinical and epidemiological description of the human outbreak, through an ethnological approach around risk factors of the disease and through an ecological approach of the ecological context of emergence, and the improvement of biological diagnosis.

Detailed description

This project is composed by monkyepox disease outbreak investigation in the CAR following national surveillance framework.

Interventions

OTHERblood samples

5 mL

OTHERScabs and pus samples

if available

Sponsors

Institut Pasteur de Bangui
CollaboratorAMBIG
Institut Pasteur
Lead SponsorINDUSTRY

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

* Human population in villages affected by monkeypox epidemics: patients who developed monkeypox and their contacts * Health care personnel (paramedics, nurses, doctors) who work or have worked in affected villages * Traditional healers, diviners * Members of villages affected by past monkeypox epidemics

Exclusion criteria

* area not accessible to investigation * refusal to participate * inability to obtain consent

Design outcomes

Primary

MeasureTime frameDescription
Proportion of monkeypox cases occuring following interhuman exposures36 monthsthrough a quantitative case-control study with an odds ratio of \>3 for an exposure factor for human-to-human transmission.
Proportion of monkeypox cases occuring following zoonotic exposures36 monthsthrough a quantitative case-control study with an odds ratio of \>3 for an exposure factor for zoonotic transmission.

Secondary

MeasureTime frameDescription
Identification and interpretation of genomic viral mutations from the viral sequences isolated from humans and animals in CAR for Phylogenetic and phylogeographic study of the monkeypox virus36 monthsidentification and interpretation of mutations, search for the common ancestor.
Measurement of the Effective reproduction rate R in CAR according to the level of immunity (smallpox vaccine immunity or orthopoxvirus-related post disease immunity).36 monthsmeasurement of the level of population natural immunity and post vaccinal immunity to determine the Effective reproduction rate R and changes in R between 2000-2020 according to the evolution of immunity (smallpox vaccine immunity or orthopoxvirus-related post disease immunity).
Identification of the characteristics associated with the environments in which human cases of monkeypox virus infection have occurred36 monthsecosystems and their recent modifications, land use, associated climatic/meteorological elements in the tropical zone (CAR, Northern DRC...).
Comparison of genetic proximities between different viral strains isolated in humans and animals in CAR and neighboring countries since 1980.36 monthsComparison of genetic proximities
measurement of the sensitivity and the specificity of the existing diagnostic tests and those developed within the framework of the project36 monthssensitivity and specificity of the existing diagnostic tests and those developed within the framework of the project, as well as the reproducibility of measurements in relation to reference tests.

Countries

Central African Republic

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026